SOPHiA GENETICS SA
Business
SOPHiA GENETICS SA is a cloud-native software technology company providing a decentralized analytics platform (SOPHiA DDM) that standardizes, computes and analyzes complex multimodal digital health data to generate clinically actionable insights. The company offers applications for clinical customers (genomics, radiomics, and multimodal analysis across oncology, rare diseases, cardiology, neurology and metabolism) and for biopharmaceutical companies (drug discovery, development and deployment support). SOPHiA GENETICS serves more than 993 hospital, laboratory and biopharma customers globally across 75 countries through direct sales and distributor partnerships, operating a decentralized network model that enables data harmonization and collective intelligence.
Summary from 20-F filed 2026-03-03
Financials
Latest annual snapshot (FY2025, period end 2025-12-31). Full statement history unavailable for this entity.
| Revenue | — |
| Net income | $-79.00M |
| Total assets | $163.03M |
| Total liabilities | $115.89M |
| Stockholders' equity | — |
| Operating cash flow | — |
Filings
Material Events
Insiders
Institutional Holders
Frequently asked questions
What is SOPHiA GENETICS SA's CIK number?
SOPHiA GENETICS SA's SEC CIK number is 0001840706 (1840706). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find SOPHiA GENETICS SA's SEC filings?
All of SOPHiA GENETICS SA's EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.